These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 29285650

  • 1. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
    [Abstract] [Full Text] [Related]

  • 2. The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Tumour Biol; 2017 Oct; 39(10):1010428317722068. PubMed ID: 28982310
    [Abstract] [Full Text] [Related]

  • 3. Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    J Endocrinol Invest; 2018 Jun; 41(6):677-689. PubMed ID: 29147952
    [Abstract] [Full Text] [Related]

  • 4. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
    Hwang HJ, Chung HS, Jung TW, Ryu JY, Hong HC, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH, Yoo HJ.
    Mol Cell Endocrinol; 2015 Apr 15; 405():25-34. PubMed ID: 25661535
    [Abstract] [Full Text] [Related]

  • 5. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
    Choi SH, Park S, Oh CJ, Leem J, Park KG, Lee IK.
    Vascul Pharmacol; 2015 Oct 15; 73():11-9. PubMed ID: 26187356
    [Abstract] [Full Text] [Related]

  • 6. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.
    Hwang HJ, Jung TW, Kim BH, Hong HC, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH, Yoo HJ.
    Biochem Pharmacol; 2015 Nov 01; 98(1):157-66. PubMed ID: 26297911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Lee SJ.
    Anticancer Res; 2018 Nov 01; 38(11):6339-6352. PubMed ID: 30396956
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study).
    Lim S, Han KA, Yu J, Chamnan P, Kim ES, Yoon KH, Kwon S, Moon MK, Lee KW, Kim DJ, Kim M, Wongtanate M, Kim EY, Kim SH, Lee MK, INICOM Study Group.
    Diabetes Obes Metab; 2017 Jan 01; 19(1):87-97. PubMed ID: 27619558
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and pharmacodynamic interaction between gemigliptin and metformin in healthy subjects.
    Shin D, Cho YM, Lee S, Lim KS, Kim JA, Ahn JY, Cho JY, Lee H, Jang IJ, Yu KS.
    Clin Drug Investig; 2014 Jun 01; 34(6):383-93. PubMed ID: 24627290
    [Abstract] [Full Text] [Related]

  • 13. Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Kim YJ, Hwang HJ, Kang JG, Kim CS, Ihm SH, Choi MG, Lee SJ.
    Anticancer Res; 2018 Jun 01; 38(6):3515-3525. PubMed ID: 29848705
    [Abstract] [Full Text] [Related]

  • 14. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo.
    Jung E, Kim J, Kim SH, Kim S, Cho MH.
    Eur J Pharmacol; 2014 Dec 05; 744():98-102. PubMed ID: 25448307
    [Abstract] [Full Text] [Related]

  • 15. Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
    Seo JB, Choi YK, Woo HI, Jung YA, Lee S, Lee S, Park M, Lee IK, Jung GS, Park KG.
    Diabetes Metab J; 2019 Dec 05; 43(6):830-839. PubMed ID: 30877711
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells.
    Esfahanian N, Shakiba Y, Nikbin B, Soraya H, Maleki-Dizaji N, Ghazi-Khansari M, Garjani A.
    Mol Med Rep; 2012 Apr 05; 5(4):1068-74. PubMed ID: 22246099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.